Patients were asking if it was safe to use their GLP-1 therapy with nodular disease and a history of thyroid cancer or concern for thyroid cancer
And for weight-loss drugmakers, every new use could catapult the drugs even further into blockbuster status
Trials report a remarkable 20.9% average weight loss with the highest dosage, making it a standout option for those needing significant weight reduction in Wesley Chapel
In One Sentence: Retatrutide, also known as Triple G, is a once-weekly injectable medication currently being researched for weight loss and Type 2 diabetes, showing promising results in early studies by targeting multiple metabolic pathways involved in appetite control and fat metabolism
Critically it provided the first evidence of the 'posttranslational processing of a polypeptide precursor into the mature functional form of the hormone by specialized proteolytic enzymes'
Can semaglutide cause long-term side effects